Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer
CS Grob, AL Danforth, GS Chopra… - Archives of general …, 2011 - jamanetwork.com
Objective: To explore the safety and efficacy of psilocybin in patients with advanced-stage
cancer and reactive anxiety. Design: A double-blind, placebo-controlled study of patients
with advanced-stage cancer and anxiety, with subjects acting as their own control, using a
moderate dose (0.2 mg/kg) of psilocybin. Setting: A clinical research unit within a large
public sector academic medical center. Participants: Twelve adults with advanced-stage
cancer and anxiety. Main Outcome Measures: In addition to monitoring safety and subjective …
cancer and reactive anxiety. Design: A double-blind, placebo-controlled study of patients
with advanced-stage cancer and anxiety, with subjects acting as their own control, using a
moderate dose (0.2 mg/kg) of psilocybin. Setting: A clinical research unit within a large
public sector academic medical center. Participants: Twelve adults with advanced-stage
cancer and anxiety. Main Outcome Measures: In addition to monitoring safety and subjective …
